YMTX Research and Charts

YMTX - Yumanity Therapeutics Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 2023-06-26 (Delayed quote data 2024-10-24)

Last 0.69	Change ⇓ -0.03 (0.00%)	Volume 6,790
	Open 0.69	High 0.69	Low 0.69

8EMA (Daily) 0.69	40EMA (Daily) 0.66	50EMA (Daily) 0.66	STO (Daily) 56.759	MACD Hist (Daily) 0.015
8EMA (Weekly) 0.662	40EMA (Weekly) 1.17	50EMA (Weekly) 1.63	STO (Weekly) 47.600	MACD Hist (Weekly) 0.143


Company Profile
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.